Institutional Ownership
Coya Therapeutics Inc
CUSIP 22407B108COMMON STOCKCOYAQ1 2026
13D / 13G Filings
14
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
14.2%
Max % of class reported
Institutional Holders
53
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
14 filings · latest Mar 12, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 12, 2026 | Dr. Reddy'S Laboratories, Inc. | 13G | 9.7% | 2.27M | SEC |
| 2 | Jan 30, 2026 | The Vanguard Group | 13G/A | 4.3% | 899.1K | SEC |
| 3 | Jan 28, 2026 | Orin Hirschman | 13G/A | 5.3% | 1.11M | SEC |
| 4 | Feb 14, 2025 | Dme Capital Management, LP | 13G/A | 9.9% | 1.65M | SEC |
| 5 | Feb 10, 2025 | Orin Hirschman | 13G/A | 8.0% | 1.33T | SEC |
| 6 | Nov 12, 2024 | Vanguard Group Inc | 13G/A | 5.5% | 845.4K | SEC |
| 7 | Nov 4, 2024 | Vanguard Group Inc | 13G/A | 5.5% | 845.4K | SEC |
| 8 | Nov 4, 2024 | Vanguard Group Inc | 13G/A | 5.5% | 845.4K | SEC |
| 9 | Feb 14, 2024 | Greenlight Capital Inc | 13G/A | 3.1% | 439.8K | SEC |
| 10 | Feb 7, 2024 | Hirschman Orin | 13G/A | 7.2% | 1.03M | SEC |
4 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Coya Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Dme Capital Management, LP | 2.34M | $9.20M |
| 2 | Aigh Capital Management LLC | 975.4K | $3.84M |
| 3 | Alyeska Investment Group, L.P. | 800.0K | $3.15M |
| 4 | Prosight Management, LP | 420.4K | $1.66M |
| 5 | Cm Management, LLC | 375.0K | $1.48M |
| 6 | Private Management Group Inc | 369.1K | $1.45M |
| 7 | Geode Capital Management, LLC | 233.4K | $919.8K |
| 8 | Marshall Wace, LLP | 225.8K | $889.6K |
| 9 | Renaissance Technologies LLC | 104.0K | $409.6K |
| 10 | Prelude Capital Management, LLC | 101.3K | $399.2K |